Immunogenicity of meningococcal polysaccharide conjugate vaccine as a replacement for meningococcal polysaccharide vaccine in children in Guangzhou, China

被引：2

作者：

He, Qing ^{[1
]}

Xiao, Jiali ^{[2
]}

Liu, Meizhen ^{[3
]}

Li, Zhencui ^{[3
]}

Xu, Jiangxiong ^{[1
]}

Zhang, Zhoubin ^{[1
]}

机构：

[1] Guangzhou Ctr Dis Control & Prevent, Guangzhou 510440, Peoples R China

[2] Guangzhou Tianhe Ctr Dis Control & Prevent, Guangzhou 510655, Peoples R China

[3] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Peoples R China

来源：

VACCINE | 2022年 / 40卷 / 09期

关键词：

vaccine; Meningococcal polysaccharide vaccine; Immunogenicity; Persistence; Meningococcal polysaccharide conjugate vaccine; PREVENTION; DISEASE;

D O I：

10.1016/j.vaccine.2021.09.021

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

To assess the durability of antibody persistence after substitution of the MPCV vaccine for the MPSV-A vaccine in children, an observational study was conducted in children who voluntarily received two doses of MPCV-AC instead of MPSV-A between March 2017 and March 2018 in Guangzhou, China. In total, 131 and 47 participants were enrolled in the 3-year-old and 6-year-old groups, respectively. In the 3-year-old group, the seroprotection rate and GMT values for Men A and Men C were raised significantly after 1 month post-dose 1 MPSV booster vaccination. All immune indicators were significantly lower in pre dose 1 MPSV booster vaccination in the 3-year-old group than after pre-dose 2 MPSV booster vaccination in the 6-year-old group. While no significant differences were found in most immune indicators between the 1-month post-dose 1 MPSV booster vaccination in the 3-year-old group and pre-dose 2 MPSV booster vaccination in 6-year-old group. The substitute meningococcal immunization schedule showed a good immunogenicity in young children, and good sequential immunogenicity with MPSV booster immunization. (c) 2021 Published by Elsevier Ltd.

引用

页码：1370 / 1375

页数：6

共 50 条

[1] Immunogenicity of the meningococcal polysaccharide conjugate vaccine in pediatric kidney transplant patients [J].

Nelson, Delphine R. ;

Fadrowski, Jeffrey ;

Neu, Alicia .

PEDIATRIC NEPHROLOGY, 2018, 33 (06) :1037-1043

[2] Immunogenicity of the meningococcal polysaccharide conjugate vaccine in pediatric kidney transplant patients [J].

Delphine R. Nelson ;

Jeffrey Fadrowski ;

Alicia Neu .

Pediatric Nephrology, 2018, 33 :1037-1043

[3] Safety and immunogenicity of quadrivalent meningococcal polysaccharide vaccine (MPV ACYW135) compared with quadrivalent meningococcal conjugate vaccine (Menactra®) in Malian children [J].

Sow, Samba O. O. ;

Tapia, Milagritos D. D. ;

Haidara, Fadima Cheick ;

Diallo, Fatoumata ;

Traore, Youssouf ;

Traore, Awa ;

Kodio, Mamoudou ;

Borrow, Ray ;

Townsend-Payne, Kelly ;

Yuan, Lin ;

Yang, Shuyuan ;

Shi, Lei ;

Chen, Jingjing ;

Fang, Guoliang ;

Lin, Jianxiang ;

Hu, Ruoyu ;

Viviani, Simonetta ;

Huang, Zhen .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)

[4] An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine [J].

Chandramohan, Daniel ;

Hodgson, Abraham ;

Coleman, Paul ;

Baiden, Rita ;

Asante, Kwaku ;

Awine, Elizabeth ;

Owusu-Agyei, Seth ;

Boutriau, Dominique ;

Nelson, Christopher B. ;

Greenwood, Brain .

VACCINE, 2007, 25 :A83-A91

[5] Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease [J].

Shao, Pei-Lan ;

Chang, Luan-Yin ;

Hsieh, Szu-Min ;

Chang, Shan-Chwen ;

Pan, Sung-Ching ;

Lu, Chun-Yi ;

Hsieh, Yu-Chia ;

Lee, Chin-Yun ;

Dobbelaere, Kurt ;

Boutriau, Dominique ;

Tang, Haiwen ;

Bock, Hans L. ;

Huang, Li-Min .

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2009, 108 (07) :539-547

[6] PEG as a spacer arm markedly increases the immunogenicity of meningococcal group Y polysaccharide conjugate vaccine [J].

Huang, Qingrui ;

Li, Dongxia ;

Kang, Aijun ;

An, Wenqi ;

Fan, Bei ;

Ma, Xiaowei ;

Ma, Guanghui ;

Su, Zhiguo ;

Hu, Tao .

JOURNAL OF CONTROLLED RELEASE, 2013, 172 (01) :382-389

[7] Preclinical immunogenicity and functional activity studies of an A plus W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines [J].

Tunheima, G. ;

Arnemo, M. ;

Naess, L. M. ;

Fjeldheim, A. K. ;

Nome, L. ;

Bolstad, K. ;

Aase, A. ;

Mandiarote, A. ;

Gonzalez, H. ;

Gonzalez, D. ;

Garcia, L. ;

Cardoso, D. ;

Norheim, G. ;

Rosenqvist, E. .

VACCINE, 2013, 31 (51) :6097-6106

[8] Safety and immunogenicity of a booster dose of meningococcal (groups A, C, W, and Y) polysaccharide diphtheria toxoid conjugate vaccine [J].

Robertson, Corwin A. ;

Greenberg, David P. ;

Hedrick, James ;

Pichichero, Michael ;

Decker, Michael D. ;

Saunders, Martha .

VACCINE, 2016, 34 (44) :5273-5278

[9] Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent Polysaccharide Vaccine [J].

Khalil, Mohamed ;

Al-Mazrou, Yagob ;

Findlow, Helen ;

Chadha, Helen ;

Castells, Valerie Bosch ;

Johnson, David R. ;

Borrow, Ray .

CLINICAL AND VACCINE IMMUNOLOGY, 2012, 19 (10) :1561-1566

[10] Quadrivalent meningococcal vaccines: Hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine [J].

Broeker, Michael ;

Veitch, Keith .

TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2010, 8 (01) :47-50

← 1 2 3 4 5 →